Overcoming Therapeutic Challenges for Pancreatic Ductal Adenocarcinoma with xCT Inhibitors

被引:1
|
作者
Vucetic, Milica [1 ]
Daher, Boutaina [1 ]
Cassim, Shamir [1 ]
Parks, Scott [2 ,3 ]
Pouyssegur, Jacques [1 ,4 ]
机构
[1] Ctr Sci Monaco CSM, Dept Med Biol, Beaulieu Sur Mer, MC, Monaco
[2] Trev & Joyce Deeley Res Ctr, BC Canc, Victoria, BC, Canada
[3] Univ Victoria, Genome British Columbia Prote Ctr, Victoria, BC, Canada
[4] Univ Cote dAzur IRCAN, CNRS, Ctr A Lacassagne, INSERM, Nice, France
来源
关键词
X(C)(-) TRANSPORTER ACTIVITY; CANCER-CELLS; CYSTINE/GLUTAMATE ANTIPORTER; CALRETICULIN EXPOSURE; IMPROVES SURVIVAL; OXIDATIVE STRESS; CYSTINE; GEMCITABINE; GLUTATHIONE; FERROPTOSIS;
D O I
10.1007/978-3-030-62026-4_2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:7 / 24
页数:18
相关论文
共 50 条
  • [1] Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities
    Min, Kay Myo K.
    Ffrench, Charlie B.
    Jessup, Claire F.
    Shepherdson, Mia
    Barreto, Savio George
    Bonder, Claudine S.
    CANCERS, 2023, 15 (08)
  • [2] Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges
    Srilatha, Mundla
    Malla, Ramarao
    Adem, Megha Priya
    Foote, Jeremy B.
    Nagaraju, Ganji Purnachandra
    SEMINARS IN CANCER BIOLOGY, 2023, 97 : 12 - 20
  • [3] Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
    Aditi Jain
    Vikas Bhardwaj
    World Journal of Gastroenterology, 2021, 27 (39) : 6527 - 6550
  • [4] Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
    Jain, Aditi
    Bhardwaj, Vikas
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (39) : 6527 - 6550
  • [5] Exploring the therapeutic potential of focal adhesion kinase inhibition in overcoming chemoresistance in pancreatic ductal adenocarcinoma
    Sciano, Fabio
    Terrana, Francesca
    Pecoraro, Camilla
    Parrino, Barbara
    Cascioferro, Stella
    Diana, Patrizia
    Giovannetti, Elisa
    Carbone, Daniela
    FUTURE MEDICINAL CHEMISTRY, 2024, 16 (03) : 271 - 289
  • [6] Pancreatic ductal adenocarcinoma: Emerging therapeutic strategies
    Osei-Bordom, Daniel C.
    Serifis, Nikolaos
    Brown, Zachary J.
    Hewitt, D. Brock
    Lawal, Gbemisola
    Sachdeva, Gagandeep
    Cloonan, Daniel J.
    Pawlik, Timothy M.
    SURGICAL ONCOLOGY-OXFORD, 2022, 43
  • [7] Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
    Chandana, Sreenivasa
    Babiker, Hani M.
    Mahadevan, Daruka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (02) : 161 - 177
  • [8] Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
    Raufi, Alexander G.
    Liguori, Nicholas R.
    Carlsen, Lindsey
    Parker, Cassandra
    Hernandez Borrero, Liz
    Zhang, Shengliang
    Tian, Xiaobing
    Louie, Anna
    Zhou, Lanlan
    Seyhan, Attila A.
    El-Deiry, Wafik S.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [9] Current Therapeutic Options for Pancreatic Ductal Adenocarcinoma
    Bisht, Savita
    Brossart, Peter
    Feldmann, Georg
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (10) : 590 - 594
  • [10] The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
    Hilmi, Marc
    Delaye, Matthieu
    Muzzolini, Milena
    Nicolle, Remy
    Cros, Jerome
    Hammel, Pascal
    Cardot-Ruffino, Victoire
    Neuzillet, Cindy
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (12): : 1129 - 1142